Vaccine News and Research

Latest Vaccine News and Research

First Edition: June 24, 2014

Today's headlines include news about the latest report detailing problems at the VA.

24 Jun 2014

State highlights: Ohio managed care plans launch; Bluecross Blueshield plan faces Ore. lawsuit; N.Y. policy on unvaccinated children upheld

A selection of health policy stories from Ohio, Oregon, New York, Colorado, Iowa, New Jersey, North Carolina, Georgia, California and Minnesota.

24 Jun 2014

Viewpoints: Concerns about ACOs; problems in Va. gov.'s strategy; Medicaid 'black hole'

Although Obamacare's health insurance expansion has directly provided coverage to only about 4 percent of Americans, changes embedded in the Affordable Care Act could affect many more people, and not always in good ways.

24 Jun 2014

FEI announces the sale of a complete correlative workflow to the University of Maastricht

FEI (NASDAQ: FEIC) announces the sale of a complete correlative workflow to the University of Maastricht. The systems will be installed at the University’s Institute of Nanoscopy, a new research facility that will use the high-resolution microscopes to understand the working mechanisms of protein complexes in an effort to develop new and improved treatment and prevention for disease, such as cancer and tuberculosis.

23 Jun 2014

First Edition: June 23, 2014

Today's early morning highlights from the major news organizations, including news stories about healthcare.gov management changes.

23 Jun 2014

New model for HIV-1 infection offers promising option for clinical research

HIV-1, the virus responsible for most cases of AIDS, is a very selective virus. It does not readily infect species other than its usual hosts — humans and chimpanzees.

20 Jun 2014

Generic drug delays cost U.S. payers millions

Problems surrounding an Indian company's launch of generic versions of three blockbuster drugs have preserved millions in revenue for the brand-name makers, reports The Wall Street Journal.

19 Jun 2014

Janssen signs license agreement with Vertex to develop, commercialize VX-787 for influenza A treatment

Janssen Pharmaceuticals, Inc.announced today that it has entered into an exclusive license agreement with Vertex Pharmaceuticals for the worldwide development, manufacturing and commercialization of VX-787, a novel medicine in Phase II development for the treatment of influenza A.

18 Jun 2014

First Edition: June 18, 2014

Today's headlines include a report that the cost of health law subsidies may push the measure's overall price tag beyond projections.

18 Jun 2014

La Jolla Institute researchers advance work toward vaccine for heart disease

Research toward the world's first vaccine for heart disease continues to advance at the La Jolla Institute for Allergy and Immunology, with researchers demonstrating significant arterial plaque reduction in concept testing in mice.

18 Jun 2014

New vaccine reprograms pancreatic tumors and makes them vulnerable to immunotherapy

Researchers at the Johns Hopkins Kimmel Cancer Center have developed and tested a vaccine that triggered the growth of immune cell nodules within pancreatic tumors, essentially reprogramming these intractable cancers and potentially making them vulnerable to immune-based therapies.

18 Jun 2014

3SBio signs exclusive license agreement with Selecta Biosciences for pegsiticase

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive license with Selecta Biosciences for pegsiticase (Uricase PEG-20), a pegylated recombinant uricase from candida utilis.

18 Jun 2014

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Alexion Pharmaceuticals (Nasdaq:ALXN) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis (MG), a rare, debilitating neurologic disorder caused by uncontrolled complement activation.

17 Jun 2014

Parents value convenience of sports physicals but recognize importance of thorough doctor visits

Nearly half of parents say any qualified health care provider - not just a child's usual provider - can do a sports physical, according to a new University of Michigan C.S. Mott Children's Hospital National Poll on Children's Health.

17 Jun 2014

Enhancing vaccine efficiency through encapsulation

A work published in Vaccine, and led by the Institut de Biotecnologia i de Biomedicina (IBB – UAB) and ICN2, studies the biodistribution and immunological efficacy protecting from infection of immunostimulant-loaded nanoliposomes in zebrafish in vivo.

17 Jun 2014

Affordable Care Act to have significant impact on patients with diabetes

The Affordable Care Act (ACA, also known as Obamacare) is dramatically changing health care delivery in the U.S. Specific parts of the new law, which will be phased in through 2020, will have a significant impact on patients with diabetes and prediabetes, as explored in a comprehensive Review article published in Diabetes Technology & Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

17 Jun 2014

Predicting dengue fever in Brazil: an interview with Dr. Rachel Lowe, Catalan Institute for Climate Sciences (IC3)

Dengue is a mosquito-transmitted viral infection. The disease is widespread in tropical and sub-tropical climates and most commonly found in urban areas. Around half of the world's population are now estimated to live in dengue endemic regions.

16 Jun 2014

Investigators study new cancer immunotherapy to help patients with advanced pancreatic cancer

Medical investigators at the Virginia G. Piper Cancer Center at Scottsdale Healthcare are studying a new cancer immunotherapy to see if it can successfully help patients with advanced pancreatic cancer.

16 Jun 2014

Longer looks: Tech-savvy health care ads; being cautious of bad hospital data

"Mom, Dad, what's wrong with me?" Michael Moscariello was a smart, thoughtful 10-year-old when that question burst out one evening before dinner. ... May Moscariello, Michael's mom, had taken him to Franciscan Hospital for Children in Boston three years earlier, in 1988.

13 Jun 2014

Findings provide new strategy for developing safe, effective vaccine against strep throat

An international team of scientists, led by researchers at the University of California, San Diego School of Medicine, have identified the genes encoding a molecule that famously defines Group A Streptococcus (strep), a pathogenic bacterial species responsible for more than 700 million infections worldwide each year.

12 Jun 2014

Vaccine News and Research

Latest Vaccine News and Research

First Edition: June 24, 2014

State highlights: Ohio managed care plans launch; Bluecross Blueshield plan faces Ore. lawsuit; N.Y. policy on unvaccinated children upheld

Viewpoints: Concerns about ACOs; problems in Va. gov.'s strategy; Medicaid 'black hole'

FEI announces the sale of a complete correlative workflow to the University of Maastricht

First Edition: June 23, 2014

New model for HIV-1 infection offers promising option for clinical research

Generic drug delays cost U.S. payers millions

Janssen signs license agreement with Vertex to develop, commercialize VX-787 for influenza A treatment

First Edition: June 18, 2014

La Jolla Institute researchers advance work toward vaccine for heart disease

New vaccine reprograms pancreatic tumors and makes them vulnerable to immunotherapy

3SBio signs exclusive license agreement with Selecta Biosciences for pegsiticase

Alexion announces that FDA grants ODD to Soliris for Myasthenia Gravis treatment

Parents value convenience of sports physicals but recognize importance of thorough doctor visits

Enhancing vaccine efficiency through encapsulation

Affordable Care Act to have significant impact on patients with diabetes

Predicting dengue fever in Brazil: an interview with Dr. Rachel Lowe, Catalan Institute for Climate Sciences (IC3)

Investigators study new cancer immunotherapy to help patients with advanced pancreatic cancer

Longer looks: Tech-savvy health care ads; being cautious of bad hospital data

Findings provide new strategy for developing safe, effective vaccine against strep throat

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in